Grabenstein J D, Hayton B D
University of North Carolina, School of Pharmacy, Chapel Hill 27599-7360.
Am J Hosp Pharm. 1990 Aug;47(8):1774-81.
The feasibility of identifying candidates for vaccination by analyzing patients' use of prescribed drugs as recorded in a computerized database was investigated. Pharmacists at a 45-bed hospital serving U.S. Armed Forces in Germany developed a list of drugs used to treat patients with diagnoses that warrant influenza or pneumococcal pneumonia vaccination. In December 1988 and April 1989, the facility's pharmacy database was searched for patients who had received the infection-risk-indicating drugs during September 1, 1988-March 30, 1989. Medical records of patients identified were screened to verify the indications for vaccination. Patients at risk were sent letters and prescriptions written by a pharmacist to inform and remind them of their need for vaccination. Of 109 patients for whom records were screened, 80 (73.4%) had valid indications for immunization. Of these 80 patients, 48 (60%) accepted the invitation to be immunized. The 80 patients in need of vaccination received 151 individual prescriptions; 77 doses (51%) were administered to 48 patients. Screening by pulmonary, cardiovascular, and hypoglycemic drug use identified the largest numbers of patients in need of vaccination, as did age over 64 years. Patients with more than one risk factor for infection were significantly more likely to accept vaccination than patients with only one risk factor. Pharmacoepidemiologic programs can help pharmacists to fulfill their role as advocates of immunization.
研究了通过分析计算机化数据库中记录的患者处方药使用情况来确定疫苗接种候选人的可行性。一家为驻德国美军服务的拥有45张床位的医院的药剂师制定了一份用于治疗诊断为需要接种流感或肺炎球菌肺炎疫苗患者的药物清单。1988年12月和1989年4月,在该机构的药房数据库中搜索了在1988年9月1日至1989年3月30日期间接受过感染风险指示药物治疗的患者。对确定的患者的病历进行筛查以核实疫苗接种指征。向有风险的患者发送药剂师撰写的信件和处方,以告知并提醒他们需要接种疫苗。在筛查了病历的109名患者中,80名(73.4%)有有效的免疫接种指征。在这80名患者中,48名(60%)接受了免疫接种邀请。80名需要接种疫苗的患者共收到151份个人处方;48名患者接种了77剂(51%)。通过肺部、心血管和降糖药物的使用情况进行筛查,确定了需要接种疫苗的患者数量最多,64岁以上的患者也是如此。有多种感染风险因素的患者比只有一种风险因素的患者更有可能接受疫苗接种。药物流行病学项目可以帮助药剂师履行其作为免疫倡导者的职责。